T1	p 200 327	borderline hypertensive patients with IDDM-type diabetes mellitus . Twenty-nine IDDM patients with borderline hypertension were
T2	p 1474 1522	diabetic patients with borderline hypertension .
T3	i 81 122	dihydropyridine calcium channel blocker :
T4	i 154 172	placebo-controlled
T5	i 184 196	nitrendipine
T6	i 350 408	placebo or nitrendipine treatment . Nitrendipine was given
T7	i 431 433	20
T8	i 538 561	non exhausting exercise
T9	i 778 786	collagen
T10	i 883 884	.
T11	i 1015 1022	placebo
T12	i 1110 1111	.
T13	i 1151 1162	stimulation
T14	i 1214 1236	nitrendipine treatment
T15	i 1307 1319	nitrendipine
T16	i 1384 1406	nitrendipine treatment
T17	o 14 44	platelet thromboxane formation
T18	o 474 504	platelet thromboxane formation
T19	o 542 561	exhausting exercise
T20	o 611 671	plasma levels of platelet factor 4 and aggregation responses
T21	o 675 691	collagen and ADP
T22	o 745 754	formation
T23	o 845 849	AA )
T24	o 912 945	thromboxane synthesis in response
T25	o 1052 1069	PF4 plasma levels
T26	o 1118 1135	blood aggregation
T27	o 1268 1279	aggregation
T28	o 1337 1350	platelet rich